Cipher Pharmaceuticals (OTCMKTS:CPHRF) Stock Price Up 4.6%

Cipher Pharmaceuticals Inc (OTCMKTS:CPHRF) (TSE:CPH) rose 4.6% during trading on Friday . The stock traded as high as $1.11 and last traded at $1.10, approximately 250 shares were traded during mid-day trading. A decline of 95% from the average daily volume of 4,869 shares. The stock had previously closed at $1.05.

The firm’s 50-day simple moving average is $0.93 and its 200 day simple moving average is $1.02.

Cipher Pharmaceuticals Company Profile (OTCMKTS:CPHRF)

Cipher Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. The company offers EPURIS (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; LIPOFEN (CIP-FENOFIBRATE), a formulation of the active ingredient fenofibrate used for the treatment of hyperlipidemia, a cholesterol disorder; CONZIP/DURELA (CIP-TRAMADOL ER), a formulation of the active ingredient tramadol for the management of moderate to moderately severe pain; and Absorica, an oral retinoid indicated for the treatment of severe recalcitrant nodular acne in patients.

Further Reading: What can cause a stock to outperform?

Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.